Dr Delamore was recorded as noting that: "a very high percentage of patients being treated for haemophilia and Christmas disease are proving after all to be infected by one type of hepatitis or another." Read more about Dr Delamore was recorded as noting that: "a very high percentage of patients being treated for haemophilia and Christmas disease are proving after all to be infected by one type of hepatitis or another."
Dr Delamore identified the incidence of hepatitis in haemophilia as being the highest priority in a March 1977 letter to Dr Rizza. Read more about Dr Delamore identified the incidence of hepatitis in haemophilia as being the highest priority in a March 1977 letter to Dr Rizza.
Dr Gunson stated that Dr Wensley "worked very hard and devised a semi-automated method for producing high quality cryoprecipitate from which the patients in the region derived considerable benefit." Read more about Dr Gunson stated that Dr Wensley "worked very hard and devised a semi-automated method for producing high quality cryoprecipitate from which the patients in the region derived considerable benefit."
Dr Wensley reported that certain batches of Factor VIII concentrate had failed to comply with the new B.P. limit. Read more about Dr Wensley reported that certain batches of Factor VIII concentrate had failed to comply with the new B.P. limit.
Dr Wensley recorded that the NHS concentrate compared well with commercial. and that he was gradually changing his home treatment patients from commercial to NHS concentrate, with the plan that commercial concentrate would then be used only in operations. Read more about Dr Wensley recorded that the NHS concentrate compared well with commercial. and that he was gradually changing his home treatment patients from commercial to NHS concentrate, with the plan that commercial concentrate would then be used only in operations.
It was observed that usage of cryoprecipitate in the North West region remained high in comparison with the national position, due to the policies adopted by the regional haemophilia service. Read more about It was observed that usage of cryoprecipitate in the North West region remained high in comparison with the national position, due to the policies adopted by the regional haemophilia service.
In 1979, NHS concentrate was used in the greatest measure at the Manchester Royal Infirmary but with large quantities of commercial concentrates and cryoprecipitate all used as well. Read more about In 1979, NHS concentrate was used in the greatest measure at the Manchester Royal Infirmary but with large quantities of commercial concentrates and cryoprecipitate all used as well.
In 1978, NHS concentrate was used in greatest measure at the Manchester Royal Infirmary, but significant quantities of commercial concentrates and cryoprecipitate were also used. Read more about In 1978, NHS concentrate was used in greatest measure at the Manchester Royal Infirmary, but significant quantities of commercial concentrates and cryoprecipitate were also used.
1977 saw an increase in the volume of NHS concentrate used at the Manchester Royal Infirmary, but a greater volume of commercial as well. Read more about 1977 saw an increase in the volume of NHS concentrate used at the Manchester Royal Infirmary, but a greater volume of commercial as well.
The annual return for 1976 showed substantial use of cryoprecipitate, NHS concentrate and Kryobulin, with some use of Hemofil. Both FEIBA and porcine Factor 8 were also used in Manchester Haemophilia Centre. Read more about The annual return for 1976 showed substantial use of cryoprecipitate, NHS concentrate and Kryobulin, with some use of Hemofil. Both FEIBA and porcine Factor 8 were also used in Manchester Haemophilia Centre.